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http:WHAT THIS PAPER ADDS
Patients with an asymptomatic abdominal aortic aneurysm tend to be informed inconsistently and incompletely
about their disorder and the treatment options open to them. A patient decision aid helps to share treatment
decisions with these patients by increasing their knowledge about the disorder and treatment options open to
them, without raising anxiety levels or deteriorating health outcomes. However, it does not reduce patient
decisional conﬂict, nor does it improve satisfaction.Objective: Abdominal aortic aneurysm patients tend to be informed inconsistently and incompletely about their
disorder and the treatment options open to them. The objective of this trial was to evaluate whether these
patients are better informed and experience less decisional conﬂict regarding their treatment options after
viewing a decision aid.
Design: A six-centre, randomised clinical trial comparing a decision aid plus regular information versus regular
information from the surgeon.
Methods: Included patients had recently been diagnosed with an asymptomatic abdominal aortic aneurysm at
least 4 cm in diameter. The decision aid consisted of a one-time viewing of an interactive CD-ROM elaborating on
elective surgery versus watchful waiting. Generally, the decision aid advised patients with aneurysms less than
5.5 cm to agree to watchful waiting, for larger aneurysms the decision aid provided insight into the balance of
beneﬁt and harm of surgical and conservative approaches, taking into account age, co-morbidity and size of the
aneurysm. The primary outcome was patient decisional conﬂict measured at 1 month follow-up (Decisional
Conﬂict Scale). Secondary outcomes were patient knowledge, anxiety and satisfaction.
Results: In 178 aneurysm patients, decisional conﬂict scores did not differ signiﬁcantly between the decision aid
and the regular information groups (22 vs. 24 on the 0e100 Decisional Conﬂict Scale; p ¼ .33). Patients in the
decision aid group had signiﬁcantly better knowledge (10.0 vs. 9.4 out of 13 points; p ¼ .04), whereas anxiety
levels (4.4 and 5.0 on a 0e21 scale; p ¼ .73) and satisfaction scores (74 and 73 on a 0e100 scale; p ¼ .81) were
similar in both groups.
Conclusion: In addition to regular patient-surgeon communication, a decision aid helps to share treatment
decisions with abdominal aortic aneurysm patients by increasing their knowledge about the disorder and
available treatment options without raising anxiety levels; however, it does not reduce decisional conﬂict, nor
does it improve satisfaction.
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Abdominal aortic aneurysm rupture carries a high mortality
rate,1 but the majority of patients remain asymptomatic
and will eventually die from another disease. Therefore, the
patient’s risk of rupture during watchful waiting should be
weighed against the beneﬁts and risks of elective aneurysm
repair. Surgeons have an ethical obligation to share these
important decisions with their patients, in addition to the
legal imperative to inform patients about their health.2 This
has been formulated in a recent statement on the role
patients should play in healthcare decisions.3
In daily practice, however, aneurysm patients tend to be
informed inconsistently about their disorder and the avail-
able treatment options, and the amount of information
given is often less than is legally required.4 Moreover,
aneurysm patients reported being unaware of their options
when making the treatment decision.5
A decision aid, used in conjunction with regular patient-
surgeon communication, may address these limitations by
informing and involving patients in the decision making
process.6 Decision aids typically contain information on
treatment options and outcomes related to the patient’s
health status and explore patient preferences and values.7
The authors had previously developed a decision aid
considering elective surgery and watchful waiting for pa-
tients with an asymptomatic abdominal aortic aneurysm.8
The aim of the current study was to evaluate whether pa-
tients recently diagnosed with an asymptomatic abdominal
aortic aneurysm beneﬁt from using this decision aid in
addition to regular information from their surgeon. Beneﬁt
was primarily deﬁned in terms of less decisional conﬂict
regarding treatment options. Furthermore, it was deter-
mined whether patients who used the decision aid were
better informed about the disorder, less likely to be anxious,
and be more satisﬁed in terms of their communication with
the surgeon. Final treatment choice and health outcomes
were also documented.
METHODS
Trial design
A six-centre, randomised clinical trial was conducted in the
Netherlands (DECAID-trial; registered as NTR1524)
comparing an additional decision aid versus regular infor-
mation as provided by the surgeon regarding elective sur-
gery and watchful waiting for asymptomatic abdominal
aortic aneurysms. The study was approved by the local
medical ethics review board of each participating centre.
The trial was designed, conducted, and described according
to the revised CONSORT statement.9“Intervention”: decision aid in addition to regular
information
The decision aid comprises an interactive computer pro-
gram provided on a CD-ROM. It presents up-to-date, evi-
dence-based information about abdominal aortic
aneurysms and their treatment options; elective aneurysmsurgery and watchful waiting, and the pros and cons of
those treatment options, as is required by European law.2
The decision aid patients with aneurysms of less than
5.5 cm were advised to agree with watchful waiting, in
keeping with available evidence at that time.10 For patients
with aneurysms of at least 5.5 cm, the decision aid provided
a comprehensive insight into the balance of beneﬁt and
harm of a surgical (open and endovascular) and a conser-
vative approach, taking age, co-morbidity, and size of the
aneurysm into account. The program also includes a num-
ber of questions that invite the patient to clarify his or her
preferences. For example: “To what extent would you be
anxious or worried about rupture if you do not get surgical
treatment?”. In the decision aid no advice towards a certain
treatment option was given to patients with aneurysms of
at least 5.5 cm. Finally, the decision to be considered by the
patient was about whether to perform elective surgery or
watchful waiting. This decision aid meets the quality criteria
for patient decision support technologies developed by the
International Patient Decision Aids Standards
Collaboration.7
Participants
Eligible patients were identiﬁed between November 2008
and June 2011 at the outpatient clinic. Inclusion criteria
were patients of at least 18 years of age, who were visiting
the outpatient clinic for the ﬁrst time with an asymptomatic
abdominal aortic aneurysm diameter of at least 4.0 cm as
conﬁrmed by ultrasonography or CT scanning. Patients also
had to understand Dutch well enough to be able to
participate in the study. Exclusion criteria were any kind of
end-stage disease resulting in estimation of life expectancy
of less than a year, or lack of necessary mental capacity to
provide informed consent.
Eligibility
During their ﬁrst contact, the consulting surgeon brieﬂy
informed the patients and asked for their verbal consent to
participate in the study. Patients received a brochure about
the study to take home. If they agreed to participate, they
provided written informed consent and returned the
baseline questionnaire to the research centre in a pre-paid
envelope.
Randomisation
Subsequently, computer-generated randomisation (ALEA v.
2.2, NKI-AVL, the Netherlands) was performed by the in-
vestigators after the informed consent form was received.
Given that aneurysm size and operative risk may inﬂuence
the extent of decisional conﬂict, minimisation was applied
to ensure a well-balanced distribution of patients. In pa-
tients with an aneurysm diameter of less than 5.5 cm,
surgery is generally not considered to be beneﬁcial ac-
cording to available evidence.10e12 The Glasgow Aneurysm
Score classiﬁes patients into low versus high risk of post-
operative complications based on the patient’s age, pre-
operative renal function, cerebrovascular and cardiac
278 A.M. Knops et al.events.13 The minimisation algorithm therefore included:
(1) aneurysm diameter either below 5.5 cm or at least
5.5 cm; and (2) Glasgow Aneurysm Score either below 81 or
at least 81. Although more recent validation studies advo-
cate other predictive models,14,15 the Glasgow Aneurysm
Score was applied here as it guided treatment decision
making and surgeons’ communication with the patient at
the time of the study.
Procedures
Patients in the control group received regular information.
Patients allocated to the decision aid received regular in-
formation, but also came to the outpatient clinic within 3
weeks of randomisation. A research assistant provided the
decision aid for one time viewing. She was present to
ensure that the program functioned properly; she was not
allowed to provide additional information or support. If
participants were unable to come to the outpatient clinic,
they were visited by the research assistant at home. All
other aspects of care for aneurysm patients in both the
decision aid and control groups (diagnostic work-up,
watchful waiting, [endo] vascular procedures) were per-
formed according to the Dutch national guideline on
abdominal aortic aneurysm treatment.16 No restrictions
were made about who has to make the treatment decision,
that is the decision aid was studied as an additional source
of information in the care of abdominal aneurysm patients.
Patients and investigators could not be blinded after
group assignment, a factor which is inherent to the decision
aid and the design of the study. Surgeons and nurses
involved in the outpatient care of the participants were
blinded to the patient’s allocation group, although patients
were not prohibited from sharing their allocation with
them.
Follow-up
Patients received questionnaires by mail 1, 4, and 10
months after randomisation.
Primary outcome. The primary outcome was decisional
conﬂict as measured by the validated Decisional Conﬂict
Scale after one month.17,18 This 16-item scale expresses the
degree of uncertainty within an individual about which
course of action to take. Scores range from 0 (none at all) to
100 (severe decisional conﬂict). The 1-month time interval
was chosen because, by then, patients were supposed to
have made their treatment decision and elective surgery
would probably not have been performed yet. Decisional
conﬂict assessment was repeated at 4 months and 10
months after the date of randomisation.
Secondary outcomes. Patient knowledge of the disorder
and treatment options was assessed by means of 13 items
of the Dutch multiple-choice Aneurysm Knowledge Ques-
tionnaire at baseline and after the 1-month follow-up.19 The
score ranges between 0 (no understanding at all) and 13
points (complete understanding). Levels of anxiety were
measured at baseline and at the 1-month, 4-month, and 10-month follow-ups, using the validated Hospital Anxiety and
Depression Scale. Employing the items which question
anxiety on this scale, the anxiety score ranges from 0 to
21.20
Patient satisfaction with respect to the conversation with
the surgeon at the outpatient clinic was assessed by means
of the Patient Satisfaction Questionnaire at baseline and
after 1-month follow-up. The validated questionnaire con-
sists of ﬁve visual analogue scales, anchored at 0 and
100.21,22 Physical quality of life was measured with the
widely used and validated Medical Outcomes Study 12-Item
Short-Form Health Survey at baseline and after all follow-up
events.23 The scale renders a score ranging from 0 to100
points.
The other outcomes were retrieved from medical records
10 months after the date of randomisation: ﬁnal treatment
choice, aneurysm rupture, possible date of surgery, and
postoperative mortality, and major morbidity. Major
morbidity was deﬁned as postoperative complications
interfering with everyday activities in the long term, such as
re-operation in the event of bowel or peripheral ischemia,
renal failure requiring dialysis, pulmonary embolus, stroke,
and myocardial infarction requiring resuscitation.24
Sample size
To estimate the necessary group size, a previous study on a
decision aid for benign prostatic hypertrophy patients was
chosen because of the similarity of the study and the likely
similarities of the sex and age distribution of the partici-
pants.25 A pre-study power analysis showed that a group
size of 85 would allow detection of a signiﬁcant difference
of 7.5 points on the 100-point Decisional Conﬂict Scale
between groups one month after inclusion with a power of
90% and at a signiﬁcance level of 0.05, assuming a mean
decisional conﬂict score of 32.5 in patients assigned to the
decision aid group and a standard deviation of 15. Allowing
for attrition of 5% during the ﬁrst month, it was planned to
include a total of 178 asymptomatic abdominal aortic
aneurysm patients.
Data collection and analysis
The total number of eligible patients was determined in
retrospect by examining the medical records of all patients
who had been documented with an abdominal aortic
aneurysm-related code during the inclusion period.
The following information was collected from patients’
medical records at baseline: aneurysm diameter, smoking
status, hypertension, hypercholesterolemia, diabetes,
stroke, transient ischemic attack, myocardial infarction,
angina pectoris, heart failure, and chronic or acute kidney
failure. At baseline, patients were also asked about their
treatment preference, if any.
Exclusion of study participants with missing values on
one or more items can cause biased results and decreases
statistical efﬁciency. For this reason, missing values in our
dataset were completed by multiple imputation analysis.
This method uses all available data to impute the missing
Not meeting inclusion criteria (n=722)
No abdominal aortic aneurysm (n=126)
Patient not newly diagnosed (n=253)
Elective surgery performed already (n=143 )
Aneurysm < 4 cm (n=165 )
Symptomatic aneurysm suspected (n=31)
Language barrier (n=4)
Assessed for eligibility (n=1072)
Follow-up at 1-month (n=81)
Excluded from analysis (n=0)
Lost to follow-up (n=10)
Life expectancy < 1 year (n=2)
Too nervous concerning aneurysm (n=1)
Language barrier for questionnaire (n=1)
Lost to follow-up (n=6)
Allocated to decision aid group (n=91)
Received allocated intervention (n=89)
Did not receive allocated intervention: elective aneurysm
repair shortly after randomisation (n=2)
Allocated to control group (n=87)
Received allocated intervention (n=87)
Lost to follow-up (n=2)
Died (n=1)
Lost to follow-up (n=1)
Follow-up at 1-month (n=85)
Excluded from analysis (n=0)
Randomised (n=178)
Not randomised (n=172)
Mentally unable (n=10)
Life expectancy < 1 year (n=18)
2nd opinion (n=17)
Missed inclusion (n=89)
Declined to participate (n=38)
Figure 1. Flowchart.
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missing values and all other variables. If one of the outcome
measures of a patient had more than 25% missing values,
that particular outcome measure of that patient was
excluded from the analyses.
All analyses were made on an intention to treat basis. For
group comparisons of continuous variables, analysis of
covariance (ANCOVA) was used, using the baseline value as
a covariate to reduce residual variance in comparisons and
to correct for possible differences in the corresponding
measure at baseline. For group comparisons of categorical
variables, the chi-square test was used or the Fisher’s exact
test in the event of an expected count below 10. A p value
less than .05 was considered to indicate a signiﬁcant dif-
ference. SPSS for Windows version 19.0 was used (IBM
SPSS, Armonk, NY, USA).
In terms of the primary outcome, two subgroup analyses
were planned: one for patients with aneurysms larger than
5.5 cm, given that these patients were expected to expe-
rience high levels of decisional conﬂict and could therefore
beneﬁt more from the decision aid; and the second for
patients with an aneurysm measuring less than 5.5 cm,
given that they were expected to experience less decisional
conﬂict because of clear-cut evidence to support perform-
ing watchful waiting at this stage.RESULTS
Out of 1,072 patients documented with an abdominal
aortic aneurysm-related code during the inclusion period,
722 appeared not to meet inclusion criteria. Another 172
patients were not randomised for the reasons shown in
Fig. 1. Eventually, 178 asymptomatic abdominal aortic
aneurysm patients participated in the study. Patients
included were predominantly male and on average just
over 70 years of age with a mean aneurysm diameter of
5.4 cm (Table 1). At baseline, about half of the patients
stated they would prefer elective surgical repair, about a
third would prefer watchful waiting, and a minority were
unsure.
Of the included patients, 176 (99%) actually received the
regular information from the surgeon or additional viewing
of the decision aid to which they were allocated (Fig. 1).
Outcomes at 1-month follow-up were available for 166
(93%). The proportion of values missing varied from 2% to
9% per outcome measure.
Decisional conﬂict scores had decreased in both ran-
domisation arms at 1-month follow-up, but without a sig-
niﬁcant difference between the decision aid group and the
control group (22 vs. 24, p ¼ .33) (Table 2). After viewing
the decision aid, patients had greater knowledge concern-
ing their disorder and the available treatment options when
Table 1. Baseline characteristics of patients in both randomisation arms.
Decision aid group
(n ¼ 91)
Control group
(n ¼ 87)
Male (%) 80 (88) 75 (86%)
Age in years (SD) 74 (8) 72 (9)
Aneurysm diameter in cm (SD) 5.3 (1.0) 5.4 (1.1)
Aneurysm <5.5 cm 52 (57) 51 (59%)
Aneurysm 5.5 cm 39 (43) 36 (41%)
Glasgow Aneurysm Score (SD) 76 (11) 75 (11)
Cerebrovascular comorbidity (%) 14 (15) 11 (13%)
Impaired kidney function (%) 5 (5) 9 (10%)
Cardiac comorbidity (%) 29 (32) 32 (37%)
Hypertension (%) 12 (13) 21 (24%)
Treated for hypertension (%) 46 (51) 26 (30%)
Diabetes (%) 12 (13) 15 (17%)
Heart failure (%) 4 (4) 2 (2%)
Dyslipidemia (%) 35 (38) 31 (36%)
COPD (%) 7 (8) 15 (17%)
Smoking (%) 33 (36) 29 (33%)
Having a partner (%) 70 (77) 68 (78%)
Having children at home (%) 7 (8) 10 (11%)
Employment Employed (%) 8 (9) 16 (18%)
Unemployed (%) 15 (18) 14 (16%)
Retired (%) 64 (70) 57 (66%)
Education Basic education (%) 49 (54) 45 (52%)
Secondary education (%) 16 (18) 23 (26%)
Higher education (%) 22 (24) 19 (22%)
Pt treatment preference Elective aneurysm repair (%) 46 (51) 40 (46%)
Conservative treatment (%) 28 (31) 29 (33%)
Unsure (%) 4 (4) 12 (14%)
Decisional Conﬂict (SD) 31 (20) 29 (18)
Knowledge about disorder (SD) 9.0 (2.5) 8.8 (2.3)
Anxiety level (SD) 4.9 (4.2) 5.7 (4.0)
Satisfaction level (SD) 77 (13) 75 (15)
Physical quality of life (SD) 45 (10) 44 (10)
COPD ¼ chronic obstructive pulmonary disease; SD ¼ standard deviation.
280 A.M. Knops et al.compared with patients allocated to the control group (10.0
vs. 9.4; p ¼ .04) (Table 2). Patient anxiety levels did not
differ between the decision aid and control group at 1-
month follow-up (4.4 vs. 5.0, p ¼ .73). All patients
expressed being satisﬁed with the information and con-
versation with the surgeon at the outpatient clinic, with no
differences between the groups (73 vs. 73, p ¼ .81).
Physical quality of life scores did not differ between patientsTable 2. Results of the outcome measures per treatment arm.
n
Decisional Conﬂict score Decision aid group 73
Control group 81
Knowledge about disorder Decision aid group 80
Control group 84
Anxiety level Decision aid group 81
Control group 85
Satisfaction level Decision aid group 74
Control group 80
Physical quality of life Decision aid group 80
Control group 84
Values are given as means (standard deviations).NA ¼ not applicable.
a Analysis of covariance test analysed differences between decision a
baseline values.in the decision aid group and those in the control group (52
vs. 53, p ¼ .27).
At 1-month follow-up, all patients had decided about
treatment. The number of patients that chose elective
aneurysm repair was similar in both arms: 39 in the decision
aid group and 36 in the control group (p ¼ .84) (Table 3).
Postoperative mortality, major morbidity, and rate of
aneurysm rupture did not differ signiﬁcantly between1 month ANCOVAa 4 months 10 months
22 (17) p ¼ .33 19 (14) 21 (17)
24 (17) 22 (17) 18 (17)
10.0 (2.2) p ¼ .04 NA NA
9.4 (2.1) NA NA
4.4 (3.6) p ¼ .73 4.2 (4.0) 4.3 (4.2)
5.0 (4.0) 4.6 (3.7) 4.5 (4.3)
74 (16) p ¼ .81 NA NA
73 (19) NA NA
44 (10) p ¼ .80 43 (11) 44 (11)
43 (10) 43 (11) 42 (11)
id group and control group at 1-month follow-up, corrected for
Table 3. Additional outcomes.
Decision aid
group
(n ¼ 91)
Control group
(n ¼ 87)
Chi-square
test
Elective aneurysm
repair performed
39 (43%) 36 (41%) p ¼ .84
Elective aneurysm
repair <5.5 cm
6/52 (12%) 8/51 (16%) p ¼ .56
Elective aneurysm
repair 5.5 cm
33/39 (85%) 28/36 (78%) p ¼ .56
Post-operative
mortality
0 (0%) 0 (0%) NA
Post-operative
major morbidity
0 (0%) 2 (6%) p ¼ .23a
Rupture during
watchful waiting
0 (0%) 3 (8%) p ¼ .12a
NA ¼ not applicable.
a Fisher’s exact test.
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decision aid.
In the subgroup of patients with an aneurysm of 5.5 cm
or more (Table 4), decisional conﬂict scores did not differ
signiﬁcantly between randomisation arms (15 in decision
aid group vs. 15 in control group, p ¼ .93). In patients with
an aneurysm of below 5.5 cm, baseline decisional conﬂict
levels appeared to be higher in contrast to baseline levels of
the other patients included (Table 4). At the 1-month
follow-up, there was no statistically signiﬁcant difference
in decisional conﬂict levels between randomisation arms for
patients with an aneurysm less than 5.5 cm (28 vs. 30,
p ¼ .19).DISCUSSION
This study shows that a treatment decision aid provided to
patients recently diagnosed with an abdominal aortic
aneurysm did not signiﬁcantly reduce decisional conﬂict
when used in addition to regular patient-surgeon commu-
nication. Patients receiving the decision aid showed greater
knowledge of their disorder and available treatment op-
tions without being more anxious. However, the decision
aid did not increase patient satisfaction or health outcomes.
As opposed to previous reviews on decision aids in sur-
gery,6,26 in the present study no signiﬁcant reduction was
found in patients’ decisional conﬂict. Moreover, decisional
conﬂict levels appeared to be lower than anticipated. This
may be because elective aneurysm surgery differs from
other types of surgery as patients are asymptomatic at the
time of making the decision while they have to consider the
risk of fatal aneurysm rupture. Therefore, it is a commonlyTable 4. Decisional Conﬂict Scale scores for subgroups of patients per
Decision aid group
Baseline 1
Abdominal aortic aneurysm <5.5 cm 35 (18) 28
Abdominal aortic aneurysm 5.5 cm 26 (22) 15
Values are given in means (standard deviations).
a Analysis of covariance test analysed differences between decision a
baseline values.accepted practice to extensively inform patients about the
surgical procedure, potential complications, prognosis, and
alternative treatment options. The unexpected ﬁnding that
patients with a small aneurysm experienced more deci-
sional conﬂict could be explained as these patients tend to
have shorter consultations with their surgeon.4 Moreover,
patients with small aneurysms might not relish the idea of
watchful waiting, that is postponing elective surgery while
running the risk of rupture between follow-up visits.
The present ﬁndings of increased patient knowledge with
unaltered anxiety levels, satisfaction, or health outcomes
are in keeping with previous studies on other decision
aids.6,26 One could doubt the relevance of the rather mar-
ginal increase in knowledge, although in a previous pilot
study patients felt better informed and claimed that the
decision aid adds value in the decision making process
about abdominal aortic aneurysms.8 Moreover, the size of
the effect does approach that of a recent systematic review
on other decision aids in surgery.6
There are two limitations of this study. First, a consider-
able number of patients could not be included, were not
asked to participate, or declined to participate. Based on
the motives recorded for declining trial participation, there
is no reason to assume that these patients differ system-
atically from the study participants; however, selection bias
may have occurred in patients that were not included.
Second, the fact that both patients and surgeons were
aware of the aim and subject of the study and could not be
blinded to the allocation may have introduced performance
bias in terms of altered communication styles. It is possible
that surgeons in the contributing centres offered more than
average information to their patients.
Future research should focus on identifying speciﬁc
subgroups of patients who may derive more beneﬁt from
the introduction of the decision aid. In this study, a greater
decline in decisional conﬂict was observed in patients with
a small aneurysm, but the study was not powered for
evaluating such effects with sufﬁcient precision. Another
group of patients who may beneﬁt more from decision aids
are those expressing the need for more explicit information
in the ﬁrst consultation with their surgeon or expressing
high decisional conﬂict scores, thereby overlooking the full
range of consequences of treatment options.27
The actual use of the decision aid in daily clinical practice
may pose some challenges.28 It is up to the surgeon to ﬁrst
acknowledge the importance of sharing this treatment de-
cision with patients. When considering the use of the de-
cision aid, the surgeon has to evaluate whether the patient
will understand the information being provided.29,30 Sometreatment arm at baseline and follow-up.
Control group ANCOVAa
month Baseline 1 month
(16) 32 (18) 30 (17) p ¼ .19
(14) 22 (16) 15 (13) p ¼ .93
id group and control group at 1-month follow-up, corrected for
282 A.M. Knops et al.patients may not understand enough about their health and
their condition to be able to make evidence-guided de-
cisions, but such patients may be hard to identify.31 Then,
some physicians in other medical specialties reported a
reluctance to use decision aids as their use would prolong
physician-patient communication.32,33 Yet, one could argue
that when patients are informed about their condition and
treatment options beforehand, actual consultation times
might be reduced and interaction optimised, as this time
can be focused on resolving remaining areas of uncertainty.
In conclusion, surgeons in clinical practice face the chal-
lenge of sharing aneurysm treatment decisions with pa-
tients. This study shows that it can be safe to use a decision
aid in addition to regular surgeon patient communication
for this purpose, as use of the decision aid did not increase
anxiety, nor did it affect health outcomes. In this way, pa-
tients can be provided with complete evidence-based in-
formation about their disease and the available treatment
options, while their preferences are being elicited as well,
irrespective of the hospital or surgeon they visited. Never-
theless, the effects of the decision aid in terms of reducing
decisional conﬂict or improving satisfaction are, at best,
very limited.CONFLICT OF INTEREST
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